A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

Clinical trial NCT05014438 · COMPLETED

Trial details

NCT number: NCT05014438
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dermatitis, Atopic

Start date: 2021-08-17
Primary completion: 2022-08-22
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.